Cognition Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Cognition Therapeutics Current Ratio Growth & History (CGTX)
Cognition Therapeutics's current ratio was 3.45 for fiscal 2025.
View full Cognition Therapeutics company overviewCognition Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 3.45 | 0.79 | +29.94% |
| 2024 | 2024-12-31 | 2.65 | −0.71 | −21.18% |
| 2023 | 2023-12-31 | 3.37 | −2.75 | −44.94% |
| 2022 | 2022-12-31 | 6.11 | −1.39 | −18.52% |
| 2021 | 2021-12-31 | 7.50 | 5.38 | +252.92% |
| 2020 | 2020-12-31 | 2.13 | — | — |
Cognition Therapeutics quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 7.03 | 5.49 | +356.12% |
| Q1 2026 | 2026-03-31 | 5.92 | 3.83 | +183.34% |
| Q4 2025 | 2025-12-31 | 3.45 | 0.79 | +29.94% |
| Q3 2025 | 2025-09-30 | 6.44 | 4.33 | +205.18% |
| Q2 2025 | 2025-06-30 | 1.54 | −1.53 | −49.85% |
| Q1 2025 | 2025-03-31 | 2.09 | −1.91 | −47.73% |
| Q4 2024 | 2024-12-31 | 2.65 | −0.71 | −21.18% |
| Q3 2024 | 2024-09-30 | 2.11 | −2.27 | −51.78% |
| Q2 2024 | 2024-06-30 | 3.07 | −2.18 | −41.48% |
| Q1 2024 | 2024-03-31 | 4.00 | −1.74 | −30.32% |
| Q4 2023 | 2023-12-31 | 3.37 | −2.75 | −44.94% |
| Q3 2023 | 2023-09-30 | 4.38 | 0.18 | +4.19% |
| Q2 2023 | 2023-06-30 | 5.25 | −2.19 | −29.45% |
| Q1 2023 | 2023-03-31 | 5.73 | −1.65 | −22.34% |
| Q4 2022 | 2022-12-31 | 6.11 | −1.39 | −18.52% |
| Q3 2022 | 2022-09-30 | 4.20 | 1.94 | +85.44% |
| Q2 2022 | 2022-06-30 | 7.44 | — | — |
| Q1 2022 | 2022-03-31 | 7.38 | — | — |
| Q4 2021 | 2021-12-31 | 7.50 | 5.38 | +252.92% |
| Q3 2021 | 2021-09-30 | 2.27 | — | — |
| Q4 2020 | 2020-12-31 | 2.13 | — | — |
Cognition Therapeutics current ratio trends
Over the last five fiscal years, Cognition Therapeutics's current ratio increased from 2.13 to 3.45, a change of 1.32. The latest reported quarter, Q2 2026, shows 7.03.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cognition Therapeutics source filings ↗